Search research articles
Contact Us
Filters
Showing results (311-320 of 325) with videos related to
Page
of 33
Sort By:
BJU International
|
March 31, 2004
Storage symptoms of the bladder: prevalence, incidence and need for services in the UK
C W McGrother, M M K Donaldson, C Shaw, et al.
Virology
|
January 30, 2024
The leader RNA of SARS-CoV-2 sequesters polypyrimidine tract binding protein (PTBP1) and influences pre-mRNA splicing in infected cells
Noelia H Altina, David G Maranon, John R Anderson, et al.
The Journal of Bone and Joint Surgery. American Volume
|
March 3, 2010
Thrombosis prevention after total hip arthroplasty: a prospective, randomized trial comparing a mobile compression device with low-molecular-weight heparin
Clifford W Colwell, Mark I Froimson, Michael A Mont, et al.
The Plant Cell
|
November 23, 2000
tA single amino acid difference distinguishes resistant and susceptible alleles of the rice blast resistance gene Pi-ta
G T Bryan, K S Wu, L Farrall, et al.
Journal of the National Medical Association
|
March 27, 2003
Relationship of internalized racism to abdominal obesity and blood pressure in Afro-Caribbean women
S E Tull, T Wickramasuriya, J Taylor, et al.
Diabetes Care
|
June 5, 2021
Effect of Recombinant Human Parathyroid Hormone (1-84) on Resolution of Active Charcot Neuro-osteoarthropathy in Diabetes: A Randomized, Double-Blind, Placebo-Controlled Study
Nina L Petrova, Nicholas K Donaldson, Maureen Bates, et al.
Diabetes Care
|
September 4, 2021
Erratum. Effect of Recombinant Human Parathyroid Hormone (1-84) on Resolution of Active Charcot Neuro-osteoarthropathy in Diabetes: A Randomized, Double-Blind, Placebo-Controlled Study. Diabetes Care 2021;44:1613-1621
Nina L Petrova, Nicholas K Donaldson, Maureen Bates, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2014
Phase 1 dose-escalation study of S-222611, an oral reversible dual tyrosine kinase inhibitor of EGFR and HER2, in patients with solid tumours
J Spicer, R Baird, A Suder, et al.
Alternatives to Laboratory Animals : ATLA
|
June 5, 2015
Non-animal Tests for Evaluating the Toxicity of Solid Xenobiotics
B Fubini, A E Aust, R E Bolton, et al.
Thorax
|
November 21, 2007
Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk
N L Mills, J J Miller, A Anand, et al.
Page
of 33
Search research articles
Search
Showing results (311-320 of 325) with videos related to
Sort By:
Page
of 33
BJU International
|
March 31, 2004
Storage symptoms of the bladder: prevalence, incidence and need for services in the UK
C W McGrother, M M K Donaldson, C Shaw, et al.
Virology
|
January 30, 2024
The leader RNA of SARS-CoV-2 sequesters polypyrimidine tract binding protein (PTBP1) and influences pre-mRNA splicing in infected cells
Noelia H Altina, David G Maranon, John R Anderson, et al.
The Journal of Bone and Joint Surgery. American Volume
|
March 3, 2010
Thrombosis prevention after total hip arthroplasty: a prospective, randomized trial comparing a mobile compression device with low-molecular-weight heparin
Clifford W Colwell, Mark I Froimson, Michael A Mont, et al.
The Plant Cell
|
November 23, 2000
tA single amino acid difference distinguishes resistant and susceptible alleles of the rice blast resistance gene Pi-ta
G T Bryan, K S Wu, L Farrall, et al.
Journal of the National Medical Association
|
March 27, 2003
Relationship of internalized racism to abdominal obesity and blood pressure in Afro-Caribbean women
S E Tull, T Wickramasuriya, J Taylor, et al.
Diabetes Care
|
June 5, 2021
Effect of Recombinant Human Parathyroid Hormone (1-84) on Resolution of Active Charcot Neuro-osteoarthropathy in Diabetes: A Randomized, Double-Blind, Placebo-Controlled Study
Nina L Petrova, Nicholas K Donaldson, Maureen Bates, et al.
Diabetes Care
|
September 4, 2021
Erratum. Effect of Recombinant Human Parathyroid Hormone (1-84) on Resolution of Active Charcot Neuro-osteoarthropathy in Diabetes: A Randomized, Double-Blind, Placebo-Controlled Study. Diabetes Care 2021;44:1613-1621
Nina L Petrova, Nicholas K Donaldson, Maureen Bates, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2014
Phase 1 dose-escalation study of S-222611, an oral reversible dual tyrosine kinase inhibitor of EGFR and HER2, in patients with solid tumours
J Spicer, R Baird, A Suder, et al.
Alternatives to Laboratory Animals : ATLA
|
June 5, 2015
Non-animal Tests for Evaluating the Toxicity of Solid Xenobiotics
B Fubini, A E Aust, R E Bolton, et al.
Thorax
|
November 21, 2007
Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk
N L Mills, J J Miller, A Anand, et al.
Page
of 33